Literature DB >> 9463682

Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum.

Z Zhang1, H Wu, S Chen, L Hu, Z Xie, Y Qiu, C Su, J P Cao, Y Wu, S Zhang, G Wu.   

Abstract

There is evidence that immunoglobulin (Ig) E antibody may be a critical component of protective immunity against Schistosoma mansoni and S. haematobium reinfection. In the present study, 555 individuals aged 3-67 years infected with S.japonicum received praziquantel treatment before the transmission season commenced; 45 d later, blood samples from 265 individuals who had no S. japonicum egg in their stool were examined by enzyme-linked immunosorbent assay for specific isotypic antibodies. Single, non-conditional logistic regression analysis showed that exposure intensity, age, soluble egg antigen (SEA)-IgE, SEA-IgM and soluble adult worm antigen-IgG4 were relevant to reinfection; multiple, non-conditional logistic regression analysis showed that exposure intensity was still a significant factor for reinfection while the SEA-IgE antibody level was associated with resistance to reinfection with S. japonicum, with a protective index of 2.00. It is suggested that this population in an area endemic for schistosomiasis japonica exhibits acquired immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9463682     DOI: 10.1016/s0035-9203(97)90047-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  25 in total

1.  Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Authors:  Carla L Black; Erick M O Muok; Pauline N M Mwinzi; Jennifer M Carter; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

2.  Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.

Authors:  Pauline N M Mwinzi; Lisa Ganley-Leal; Carla L Black; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

3.  Down-regulation of specific antigen-driven cytokine production in a population with endemic Schistosoma japonicum infection.

Authors:  L Shen; Z S Zhang; H W Wu; R E Weir; Z W Xie; L S Hu; S Z Chen; M J Ji; C Su; Y Zhang; Q D Bickle; S N Cousens; M G Taylor; G L Wu
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

4.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

5.  Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.

Authors:  Mario Jiz; Jennifer F Friedman; Tjalling Leenstra; Blanca Jarilla; Archie Pablo; Gretchen Langdon; Sunthorn Pond-Tor; Hai-Wei Wu; Daria Manalo; Remigio Olveda; Luz Acosta; Jonathan D Kurtis
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

6.  Schistosoma mansoni infection in a rural area of the Jequitinhonha Valley, Minas Gerais, Brazil: analysis of exposure risk.

Authors:  Wesley Rodrigues Pereira; Helmut Kloos; Sara B Crawford; Jorge Gustavo Velásquez-Melendez; Leonardo Ferreira Matoso; Ricardo Toshio Fujiwara; Guilherme Grossi Lopes Cançado; Philip T Loverde; Rodrigo Correa-Oliveira; Andrea Gazzinelli
Journal:  Acta Trop       Date:  2009-09-16       Impact factor: 3.112

7.  Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures.

Authors:  Marc P Hübner; Marina N Torrero; Edward Mitre
Journal:  Vaccine       Date:  2009-12-23       Impact factor: 3.641

8.  Whole-Proteome Differential Screening Identifies Novel Vaccine Candidates for Schistosomiasis japonica.

Authors:  Hannah W Wu; Sangshin Park; Sunthorn Pond-Tor; Ron Stuart; Sha Zhou; Yang Hong; Amanda E Ruiz; Luz Acosta; Blanca Jarilla; Jennifer F Friedman; Mario Jiz; Jonathan D Kurtis
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

9.  Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.

Authors:  N Rujeni; N Nausch; N Midzi; T Mduluza; D W Taylor; F Mutapi
Journal:  Parasite Immunol       Date:  2012-06       Impact factor: 2.280

10.  Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.

Authors:  Colin M Fitzsimmons; Sarah Joseph; Frances M Jones; Claus M Reimert; Karl F Hoffmann; Francis Kazibwe; Gachuhi Kimani; Joseph K Mwatha; John H Ouma; Edridah M Tukahebwa; Henry C Kariuki; Birgitte J Vennervald; Narcis B Kabatereine; David W Dunne
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.